Antibody-assisted target identification reveals afatinib, an EGFR covalent inhibitor, down-regulating ribonucleotide reductase

Oncotarget
Cheng-Han YuGeen-Dong Chang

Abstract

Afatinib, used for the first-line treatment of non-small-cell lung carcinoma (NSCLC) patients with distinct epidermal growth factor receptor (EGFR) mutations, inactivates EGFR by mimicking ATP structure and forming a covalent adduct with EGFR. We developed a method to unravel potential targets of afatinib in NSCLC cells through immunoprecipitation of afatinib-labeling proteins with anti-afatinib antiserum and mass spectrometry analysis. Ribonucleotide reductase (RNR) is one of target proteins of afatinib revealed by this method. Treatment of afatinib at 10-100 nM potently inhibited intracellular RNR activity in an in vitro assay using permeabilized PC-9 cells (formerly known as PC-14). PC-9 cells treated with 10 μM afatinib displayed elevated markers of DNA damage. Long-term treatment of therapeutic concentrations of afatinib in PC-9 cells caused significant decrease in protein levels of RNR subunit M2 at 1-10 nM and RNR subunit M1 at 100 nM. EGFR-null Chinese hamster ovary (CHO) cells treated with afatinib also showed similar effects. Afatinib repressed the upregulation of RNR subunit M2 induced by gemcitabine. Covalent modification with afatinib resulting in inhibition and protein downregulation of RNR underscores the therape...Continue Reading

References

Jan 1, 1990·Methods in Enzymology·S C Pomerantz, J A McCloskey
Oct 3, 1999·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·C TolisG Giaccone
Jun 28, 2001·Oncogene·J Mendelsohn, J Baselga
Dec 26, 2001·Chemical Reviews·S M Jones, A Kazlauskas
May 26, 2004·Biochimica Et Biophysica Acta·Matthias KolbergK Kristoffer Andersson
Aug 27, 2004·Proceedings of the National Academy of Sciences of the United States of America·William PaoHarold Varmus
Sep 6, 2005·Pharmacogenetics and Genomics·Danxin WangWolfgang Sadée
Jul 11, 2006·Nature Reviews. Molecular Cell Biology·Ami Citri, Yosef Yarden
Feb 8, 2008·Nature Reviews. Cancer·Thomas HelledayRicky A Sharma
Sep 10, 2008·Nature Biotechnology·Jordi MestresRicard V Solé
Sep 11, 2008·Journal of Cell Science·Rong-Hua Tao, Ichi N Maruyama
Sep 18, 2009·The Journal of Clinical Investigation·Lucia RegalesWilliam Pao
Jul 20, 2010·Future Medicinal Chemistry·Douglas S JohnsonBenjamin F Cravatt
Aug 4, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Timothy A YapRuth Plummer
Apr 2, 2011·Nature Reviews. Drug Discovery·Juswinder SinghAdrian Whitty
May 25, 2012·Journal of Medicinal Chemistry·Tjeerd Barf, Allard Kaptein
Aug 14, 2012·The Journal of Pharmacology and Experimental Therapeutics·Flavio SolcaGuenther R Adolf
Jan 29, 2013·Molecular BioSystems·Yushi FutamuraHiroyuki Osada
Feb 27, 2013·Chemistry & Biology·Qingsong LiuNathanael S Gray
Mar 8, 2013·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Meng ZhangLiMing Wang
May 15, 2013·Progress in Molecular Biology and Translational Science·Md Faiz Ahmad, Chris G Dealwis
Jun 21, 2013·The New England Journal of Medicine·Michael L WangKristie A Blum
Jun 21, 2013·The New England Journal of Medicine·John C ByrdSusan O'Brien
Jul 3, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Lecia V SequistMartin Schuler
Jul 3, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·James Chih-Hsin YangLecia V Sequist
Aug 8, 2013·Journal of Medicinal Chemistry·Jens-Uwe Peters
Aug 29, 2013·Drugs·Rosselle T Dungo, Gillian M Keating
Dec 4, 2013·Trends in Cell Biology·Alejandra TomasEmily R Eden
Dec 24, 2013·F1000Research·Ye Hu, Jürgen Bajorath
Feb 22, 2014·ACS Chemical Biology·Hong WuNathanael S Gray
May 3, 2014·Expert Opinion on Pharmacotherapy·Xiaosong Zhang, Pamela N Munster

❮ Previous
Next ❯

Citations

Nov 20, 2020·International Journal of Cancer. Journal International Du Cancer·Philippe GironJacques De Grève
Aug 30, 2019·Journal of Medicinal Chemistry·I-Shan HsiehChing S Chen

❮ Previous
Next ❯

Methods Mentioned

BETA
immunoprecipitation
pull down
flow cytometry
xenograft
ELISA

Software Mentioned

Proteome Discoverer
TISTA
Mascot

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.